Suchergebnisse - "Van Hyfte, Grace"

PubPharm (10)

1

Neuropsychiatric complications of coronavirus disease 2019 : Mount Sinai Health System cohort study

enthalten in: Journal of neurology | 2024

von Gururangan, K. | Peschansky, V. | Van Hyfte, G. | +31

2

Molecular and cellular similarities in the brain of SARS-CoV-2 and Alzheimer’s disease individuals

enthalten in: bioRxiv.org | 2024

von Griggs, E. | Trageser, K. | Naughton, S. | +9

3

Emotional and Financial Stressors in New York City During the COVID-19 Pandemic : A Consecutive Cross-Sectional Analysis

enthalten in: Journal of racial and ethnic health disparities | 2024

von Heller, D. | Madden, D. | Berhane, T. | +12

4

Older adults with epilepsy and COVID-19 : Outcomes in a multi-hospital health system

enthalten in: Seizure | 2024

von Ufongene, C. | Van Hyfte, G. | Agarwal, P. | +16

5

In-hospital outcomes in patients with and without epilepsy diagnosed with COVID-19-A cohort study

enthalten in: Epilepsia | 2023

von Ufongene, C. | Van Hyfte, G. | Agarwal, P. | +31

6

Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials : An Analysis of the National Institutes of Health Clinical Trials Registry from 2012-2022

enthalten in: Acta haematologica | 2023

von Sastow, D. | Van Hyfte, G. | Feld, J. | +3

7

Recapitulation of pathophysiological features of AD in SARS-CoV-2-infected subjects

enthalten in: eLife | 2023

von Griggs, E. | Trageser, K. | Naughton, S. | +9

UpdateOf: bioRxiv. 2022 Nov 23;:. - PMID 36451886

8

Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors

enthalten in: Frontiers in oncology | 2023

von Wu, Y. | van Hyfte, G. | Özbek, U. | +22

9

Molecular and cellular similarities in the brain of SARS-CoV-2 and Alzheimer's disease individuals

enthalten in: bioRxiv : the preprint server for biology | 2022

von Griggs, E. | Trageser, K. | Naughton, S. | +9

UpdateIn: Elife. 2023 Jul 07;12:. - PMID 37417740

10

Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification

enthalten in: Blood advances | 2022

von Etra, A. | Gergoudis, S. | Morales, G. | +32

1
[1]